Filter your results
- 4
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 1
- 2
- 1
- 1
|
|
sorted by
|
|
Tumor Molecular Profiling: Pediatric Results of the ProfiLER Study JCO precision oncology, 2020, 4, pp.785-795. ⟨10.1200/PO.20.00023⟩
Journal articles
hal-03851844v1
|
||
|
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialMedical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Journal articles
hal-03915456v1
|
||
Genomics to select treatment for patients with metastatic breast cancerNature, 2022, 610 (7931), pp.343-348. ⟨10.1038/s41586-022-05068-3⟩
Journal articles
hal-03867787v1
|
|||
|
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung TrialCLINICAL CANCER RESEARCH, 2022, 28 (18), pp.4018-4026. ⟨10.1158/1078-0432.CCR-22-0371⟩
Journal articles
hal-04084975v1
|